A competition for cancer cells and human medical testing – How to use liquid biopsy to break through the testing dilemma?

How to improve the testing accuracy? The key is to sample and QC correctly!

Liquid biopsy has been selected by MIT Technology Review as one of the top 10 breakthrough technologies in 2015. It can be used for Non-Invasive Prenatal Testing (NIPT), early screening for disease, companion diagnostics, dynamic monitoring, cancer relapsing prediction, and prognosis evaluation. This is done by collecting specific biomarkers in patient’s body fluid including blood, saliva, and urine etc. Compared to traditional invasive sampling, it is convenient, instantaneous and minimally invasive. Moreover, it can improve the acceptance of subjects. In recent years, related research and application have become more extensive, and the future of liquid biopsy in clinical application is arriving.

Click Here for Whole Story